Learn More
PURPOSE This study assessed whether maintenance therapy with carboxyaminoimidazole (CAI), compared to placebo, prolonged overall survival in stage IIIB/IV NSCLC patients who had tumour regression or(More)
PURPOSE This study was undertaken to explore the response rate of a first-line, three-drug regimen that consisted of bortezomib, paclitaxel, and carboplatin in patients with metastatic adenocarcinoma(More)
PURPOSE A phase II study was conducted to determine the efficacy and toxicity of radiotherapy with concomitant gemcitabine and cisplatin for patients with locally advanced pancreatic adenocarcinoma.(More)
4121 Background: In vitro studies suggest that low dose GEM sensitizes cells to RT for 48 hours following exposure. CIS is a radiation sensitizer and may result in synergistic cytotoxicity when(More)
  • 1